Clinical Trial Update: Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates centrally confined 8 Gy in 1 fraction to the tumor core followed by concurrent chemoradiotherapy for unresectable stage III non-sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Locally-Advanced Non-Small Cell Lung Cancer, Radiotherapy | Phase 1 | Status: NOT_YET_RECRUITING